Scientists have used magnetism to activate tiny groups of cells in the brain, inducing bodily movements that include running, rotating and losing control of the extremities -- an achievement that could lead to advances in studying and treating neurological disease.
Working with fruit flies, scientists have identified different labels that attract and control specific nerves. In theory, the 'right' labels may re-form nervous connections if delivered to the site of injury.
New findings from a nationwide program that links neurologists with patients with Parkinson's disease in their homes via video conferencing shows that telemedicine can successfully deliver quality care. The study, which appears today in the journal Neurology, points to a new way to improve care for people who suffer from the disease, but may have not have access to a neurologist.
For people with Parkinson's disease, seeing a neurologist by video conference from their homes may be as effective as their usual in-person care with their local physician, according to a new study published in the Aug. 16, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Korean researchers have identified the early neuropathic mechanism of degenerative brain diseases and suggested ways to restore early neuropathy. It is expected to be used in the development of therapeutic agents for early neuropathy of degenerative brain diseases.
In a study that augurs well for the therapeutic potential of klotho - a life-extending protein hormone that a minority of people naturally produce at high levels - scientists at UC San Francisco have found that administering a fragment of the klotho protein to young, aging or impaired mice rapidly improves their cognitive and physical performance.
Scientists at UC San Diego have provided the first evidence that lysosomes, specialized structures found in nearly every cell in your body, can travel to distant parts of neurons to branch-like areas known as dendrites. Lysosomes help keep balance in the brain by removing material that is no longer needed, a key function that could be associated with disorders such as Parkinson's and Alzheimer's.
Researchers at MIT and Massachusetts General Hospital have devised a new way to monitor sleep without any kind of sensors attached to the body. Their sensor uses low-power radio waves that detect small changes in body movement caused by the patient's breathing and pulse, then translates those measurements into sleep stages: light, deep, or rapid eye movement (REM).
A new technique for evaluating drug safety is designed to be affordable and can detect stress on cells at earlier stages than conventional methods. It is the first with a fluorescent sensor that turns on when proteins begin to clump together -- an early sign of a process that occurs in Alzheimer's and other diseases.
Researchers at the University of Pennsylvania have developed a set of tools to observe, monitor and quantify how misfolded proteins associated with Parkinson's disease enter neurons in laboratory cultures and what happens to them once they're inside.